Related Experiment Video

Updated: Jun 25, 2026

Evaluating the Effectiveness of Cancer Drug Sensitization In Vitro and In Vivo
09:19

Evaluating the Effectiveness of Cancer Drug Sensitization In Vitro and In Vivo

Published on: February 6, 2015

Modulation of effector caspase cleavage determines response of breast and lung tumor cell lines to chemotherapy

Charles A Odonkor1, Samuel Achilefu

  • 1Department of Radiology, Washington University School of Medicine, St Louis, MO 63110, USA.

Cancer Investigation
|February 26, 2009
PubMed

Insights

Tumors can resist chemotherapy by blocking caspase activation, a key process in programmed cell death (apoptosis). Enhancing caspase activity may improve cancer drug effectiveness and prevent tumor recurrence.

Area of Science:

  • Biochemistry
  • Molecular Biology
  • Oncology

Background:

  • Caspases are crucial for drug-induced apoptosis in cancer treatment.
  • Mechanisms by which tumors evade caspase-mediated cytotoxicity remain unclear.

Purpose of the Study:

  • To investigate the role of caspase-3 and caspase-7 in tumor cell response to chemotherapy.
  • To explore the link between temporal apoptotic response, caspase activation, and drug resistance.

Main Methods:

  • Utilized breast and lung tumor cell lines.
  • Assessed caspase-3 and caspase-7 activation in response to chemotherapeutic agents.
  • Monitored tumor growth restoration after drug withdrawal.

Main Results:

  • Early apoptotic response correlated with weak caspase activation; late response with strong activation.
  • Tumor growth restoration post-drug withdrawal depended on the degree of caspase-3 and caspase-7 cleavage blockage.
  • Identified an unrecognized role of caspase modulation in tumor recurrence.

Conclusions:

  • Temporal apoptotic response is linked to caspase activation and drug resistance.
  • Endogenous blockage of caspase cleavage contributes to tumor recurrence.
  • Targeting caspase cleavage presents a rational strategy to enhance anticancer drug potency.

More Related Videos

Live Imaging of Drug Responses in the Tumor Microenvironment in Mouse Models of Breast Cancer08:26

Live Imaging of Drug Responses in the Tumor Microenvironment in Mouse Models of Breast Cancer

Published on: March 24, 2013

Related Concept Videos

Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Caspases01:24

Caspases

Caspase, a family of cysteine proteases, serve as effectors in apoptosis. The ced3 gene in C.elegans was first identified to be involved in apoptosis. This gene encodes the ced-3 caspase that is similar to the interleukin-1-beta converting enzyme or ICE in mammals. In addition to apoptosis, caspases also function in the inflammatory response. Inflammatory caspases are essential in activating pro-inflammatory cytokines that recruit immune cells and block the replication of pathogens inside cells.
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...